[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-359382-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-359382-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","t-cells-at-the-interface-of-innate-and-adaptive-immunity-in-cancer","γδ T cells at the interface of innate and adaptive immunity in cancer","","γδ T cells are unconventional lymphocytes that connect innate and adaptive immunity by recognizing stress-induced ligands independently of classical major histocompatibility complex molecules, while still supporting clonal expansion and long-term adaptation. Their semi-invariant T-cell receptor, butyrophilin, and natural killer-like receptor features position them as potent tumor effector cells against immune escape. Distinct γδ subsets show specialized phenotypes and tissue residency, enabling engineered and platform-diverse therapeutic study. The review argues for integrating γδ T cells into next-generation, individualized combinatorial cancer treatment strategies.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/t-cells-at-the-interface-of-innate-and-adaptive-immunity-in-cancer/359382/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/t-cells-at-the-interface-of-innate-and-adaptive-immunity-in-cancer/359382.png","ImageObject",300,407,{"name":42,"@type":43},"Connor ","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How do γδ T cells bridge innate and adaptive immunity in cancer?","Question",{"text":63,"@type":64},"They combine rapid innate-like recognition of stress-induced ligands with adaptive capabilities such as clonal expansion and long-term adaptation, enabling effective anti-tumor responses.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What distinguishes γδ T cell recognition from classical αβ T cells?",{"text":68,"@type":64},"γδ T cells detect multiple ligands, including phosphoantigens, lipids, and non-classical stress-induced molecules, largely independently of classical MHC processing.",{"name":70,"@type":61,"acceptedAnswer":71},"Why are γδ T cell subsets considered useful for tailored cancer therapies?",{"text":72,"@type":64},"Different γδ subsets can exhibit distinct phenotyping and specific tissue residency, allowing immunological responses to be modulated using subset specialization and engineered approaches.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},359382,1790187113,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},687207022233,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Open access Review  \n γδ T cells at the interface of innate and adaptive immunity in cancer  \nArnau Solé Casaramona  ,1,2,3 Martin F Bachmann,1,2,4 Eva Sevick-Muraca,5 Mona O Mohsen1,2,6  \nTo cite: Solé Casaramona A, Bachmann MF, SevickMuraca E, et al. γδ T cells at the interface of innate and adaptive immunity in cancer. Journal for ImmunoTherapy of Cancer 2026;14:e013668 . doi:10 . 1136/ jitc-2025-013668  \nAccepted 20 February 2026  \n© Author(s) (or their employer(s)) 2026. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.  \n1Department of Rheumatology Immunology and Allergology, Inselspital University Hospital, University of Bern, Bern, Switzerland  \n2Department for BioMedical Research, University of Bern, Bern, Switzerland  \n3Graduate School for Cellular and Biomedical Sciences (GCB), University of Bern, Bern, Switzerland  \n4Nuffield Department of Medicine, The Henry Welcome Building for Molecular Physiology, The Jenner Institute, University of Oxford, Oxford, UK 5Center for Molecular Imaging, Brown Foundation Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA 6DeepVax GmbH, Zürich, Switzerland  \nCorrespondence to  \nArnau Solé Casaramona; [arnau.sole@unibe.ch](arnau.sole@unibe.ch)  \nABSTRACT  \nγδ T cells are unconventional lymphocytes that bridge innate and adaptive immunity by combining recognition of stress-induced ligands independently of classical major histocompatibility complex molecules with the capacity to undergo clonal expansion and long-term adaptation. Their unusual ability to detect malignant transformation using semi-invariant T-cell receptors, butyrophilin recognition and natural killer-like receptors positions them as powerful effector cells in tumors that evade classical immune escape mechanisms. Furthermore, distinct γδ subsetshave distinct phenotyping and specific tissue-residencies, which could be leveraged to modulate immunological responses. We evaluate engineered therapies and different experimental platforms for studying γδ T cell biology. We conclude that next-generation cancer treatments should strategically integrate γδ T cells into synthetic immunology, individualized modeling, and combinatorial regimes.  \nINTRODUCTION γδ T-CELL OVERVIEW  \nThe concept of innate versus adaptive immunity was developed during the first half of the 20th century and has guided immunological research for multiple decades.1 However, recent discoveries of new immune populations have challenged this binary classification, like γδ T cells.1 These immune cells have demonstrated a dual nature by using innate pattern recognition alongside rapid effector functions and adaptive features including antigen specificity, clonal expansion, and memory-like phenotype.2  \nUnlike αβ T cells, γδ T cells detect various ligands independently of classical major histocompatibility complex (MHC) molecules, including phosphoantigens, lipids, and non-classical stress-induced molecules.3 4 Their semi-invariant T-cell receptors (TCRs), natural killer (NK)-like receptors, and pattern recognition receptors (PRRs) enable rapid detection of cellular stress and malignant transformations, outside conventional antigen-processing pathways.2  \nThe γδ T-cell population consists of a heterogeneous lymphocyte lineage shaped by TCR repertoire constraints, subset-specific transcriptional programs,5 and tissue-derived  \nsignals.5–7 Their subset classification, distinct tissue tropism, and dominant functional programs vary across species1 (table 1) .  \nRegardless of species-specific differences, core functional hallmarks of γδ T cells are conserved.8 For example, the capacity of rapid cytokine expression, killing activity, stress sensing, as well as the ability to shape other immune effectors in the TME.9 Indeed, these attributes render γδ T cells uniquely capable of mediating the bridge between innate and adaptive immuni","cbCaijC1XpIOJinI","https://ap.wps.com/l/cbCaijC1XpIOJinI","pdf",2697347,13,"English","# γδ T-cell overview\n## Innate vs adaptive immunity and the γδ exception\n## Ligand recognition and receptor features\n## Heterogeneity and conserved hallmarks across species\n# γδ T-cell development and subset diversity\n## Developmental control of subset formation\n## Species differences and conserved functions\n# Engineered therapies and experimental platforms\n## Studying γδ T-cell biology for translational insight\n# Therapeutic integration and clinical translation\n## Next-generation strategy for cancer treatment","[{\"question\":\"How do γδ T cells bridge innate and adaptive immunity in cancer?\",\"answer\":\"They combine rapid innate-like recognition of stress-induced ligands with adaptive capabilities such as clonal expansion and long-term adaptation, enabling effective anti-tumor responses.\"},{\"question\":\"What distinguishes γδ T cell recognition from classical αβ T cells?\",\"answer\":\"γδ T cells detect multiple ligands, including phosphoantigens, lipids, and non-classical stress-induced molecules, largely independently of classical MHC processing.\"},{\"question\":\"Why are γδ T cell subsets considered useful for tailored cancer therapies?\",\"answer\":\"Different γδ subsets can exhibit distinct phenotyping and specific tissue residency, allowing immunological responses to be modulated using subset specialization and engineered approaches.\"}]","γδ T cells at the interface of innate and adaptive immunity in cancer | PDF",1790136788,33,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aa7e771ab2838d93a7c68bcb2030f18b.webp",983,1310,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/de89c86e2c752a8dd4c21fb2e061ad65.webp",982,1309,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ed9da0a5abbe7e42600377827f34cb62.webp",981,1308,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/89af1934bf3d28b88214a04a741b2773.webp",980,1306]